Description
Book SynopsisI. Subcellular Basis of Heart Failure.- 1. Tumor Necrosis Factor-Alpha in Chronic Heart Failure.- 2. Myocardial Ribonuclease Activity in Heart Failure.- 3. ?-Adrenergic Receptor Mechanisms in Heart Failure.- 4. Vascular ?-Adrenergic Function in Congestive heart Failure.- 5. Altered Myocardial Neurotransmitter and 1,2-Diacylglycerol Concentrations in Right Ventricular Hypertrophy and Failure in Rats.- 6. Metabolic Changes in Nonischemic Myocardium During Pump Failure.- 7. Cardiac Extracellular Matrix and its Role in the Development of Heart Failure.- 8. SHHF/Mcc-fa3cp Rat Model: A Genetic Model of Congestive Heart Failure.- 9. Left Ventricular Mass and Diastolic Function in Young Individuals with a first elevated Casual Blood Pressure.- 10. Factors Responsible for Left Ventricular Underfilling in Pure Mitral Stenosis.- 11. Improved Preservation of Myocardial ultrastructure in Perfusion-Fixed Human Heart Expiants.- 12. Involvement of Leukotoxin in the Pathogenesis of Patients with Extensive Burns.- 13. Differential Regulation of Calmodulin-Dependent Cyclic Nucleotide Phosphodiesterase Isozymes.- II. Pathophysiologic Aspects of Cardiomyopathies.- 14. Adriamycin Cardiomyopathy and its Prevention in an Animal Model.- 15. Alterations in Sarcolemmal Phospholipid Base Exchange Enzymatic Activities in Diabetic Cardiomyopathy.- 16. Myocardial Lipid Peroxidation and Diabetes.- 17. Molecular Biologic Changes of Adenine Nucleotide Translocator in J-2-N Cardiomyopathic Hamsters.- 18. Renin-Angiotensin System and the Congenital Cardiomyopathic Hamster.- 19. Dietary Mercury Induces Congestive Cardiomyopathy in the Arctic.- 20. Peripheral Resistance to Atrial Natriuretic Peptide in Patients with Idiopathic Dilated.- 21. Effect of Ethanol on Allylamine-Induced SubendocardialFibrosis.- 22. Nitric Oxide: Friend and Foe in Myocardial Ischemia and Reperfusion.- 23. Role of Leukocytes and Subcellular Abnormalities in Diastolic Dysfunction During Ischemia-Reperfusion.- 24. Calcium Channel Blockade Ameliorates Cardiac Dysfunction and Failure in Ischemic Cardiomyopathy.- 25. Alterations in Autonomic Nervous System and Heart Mitochondrial Function in Rats Treated with Cyclophosphamide.- III. Treatment of Heart Failure.- 26. Combined Aerobic and Strength Training in Congestive Heart Failure Patients: Pilot Project on Safety and Feasibility.- 27. Factors Relating to 6 Minute Walk Performance in Heart Failure Patients.- 28. Dynamic Cardiomyoplasty: Management of Heart Failure Using Autologous Skeletal Muscle.- 29. Cardiac Cell Transplantation.- 30. Effects of Catalase on Volume-Overload Heart Failure.- 31. Major Determinants of Survival and Nonsurvival of Intra-aortic balloon Pumping.- 32. End-Stage Ischemic Heart Disease: Effects of Complete Myocardial Revascularization and Left Ventricular Patch Repair Following Scar Resection 369.- 33. Acute Enoximone Effect on Systemic Hemodynamics, Renal Function, and Hormonal Activation in Patients with Heart Failure.- 34. Angiotensin II Receptor Antagonist, E-4177, Inhibits Progression of Reactive Cardiac Hypertrophy Associated with Myocardial Infarction in Rats.- 35. Effects of Catecholamine and Amrinone on the Metabolism of Noninfarcted Myocardium in Cardiogenic Shock.- 36. Effects of Angiotensin Converting Enzyme Inhibitors on Acute Heart Failure Induced in the Anesthetized Dog with Microsphere Injection.- 37. Recruitment of Ventricular Function with Adjunctive Nitrate Therapy After Late Reperfusion.- 38. Neuromuscular Assessment of Heart Failure Patients.
Table of ContentsPreface. I: Subcellular Basis of Heart Failure. 1. Tumor Necrosis Factor Alpha in Chronic Heart Failure; T. Bachetti, et al. 2. Myocardial Ribonuclease Activity in Heart Failure; P. J. O'Brien, et al. 3. Beta-Adrenergic Receptor Mechanisms in Heart Failure; R. Sethi, et al. 4.Vascular alpha-Adrenergic Function in Congestive Heart Failure; Q.P. Feng, J.M.O. Arnold. 5. Altered Myocardial Neurotransmitter and 1,2-Diacylglycerol Concentrations in Right Ventricular Hypertrophy and Failure in Rats; K. Okumura, et al. 6. Metabolic Changes in Non-Ischemic Myocardium During Pump Failure; H. Ishioka, et al. 7. The Cardiac Extracellular Matrix and Its Role in the Development of Heart Failure; H. Ju, I.M.C. Dixon. 8. The SHHF/Mcc-facp Rat Model: A Genetic Model of Congestive Heart Failure; S.A. McCune, et al. 9. Left Ventricular Mass and Diastolic Function in Young Individuals with a First Elevated `Casual' Blood Pressure; S.M. De Lena, et al. 10. Factors Responsible for Left Ventricular Underfilling in Pure Mitral Stenosis; A. Surdacki, et al. 11. Improved Preservation of Myocardial Ultrastructure in Perfusion-Fixed Human Heart Explants; A.M. Gerdes, et al. 12. Involvement of Leukotoxin in Pathogenesis of Patients with Extensive Burns; K. Kosaka, et al. 13. Differential Regulation of Calmodulin-Dependent Cyclic Nucleotide Phosphodiesterase isozymes; R.K. Sharma, et al. II: Pathophysiological Aspects of Cardiomyopathies. 14. Adriamycin Cardiomyopathy and Its Prevention in an Animal Model; N. Siveski-Iliskovic, et al. 15. Alterations in Sacrolemmal Phospholipid Base Exchange Enzymatic Activities in Diabetic Cardiomyopathy; A. Vecchini, et al. 16. Myocardial Lipid Peroxidation and Diabetes; S.K. Jain. 17. Molecular Biological Changes of Adenine Nucleotide Translocator in J-2-N Cardiomyopathic Hamsters; M. Kato, et al. 18. The Renin&endash;Angiotensin System and the Congenital Cardiomyopathic Hamster; C. Lambert, et al. 19. Dietary Mercury Induces Congestive Cardiomyopathy in the Arctic; I. Asmussen. 20. Peripheral Resistance to Atrial Natriuretic Peptide in Patients with Idiopathic Dilated Cardiomyopathy; G. Iervasi, et al. 21. The Effect of Ethanol on Allylamine-Induced Subendocardial Fibrosis; K. Kato, et al. 22. Nitric Oxide: Friend and Foe in Myocardial Ischemia and Reperfusion; R.C. Kukreya. 23. Role of Leukocytes and Subcellular Abnormalities in Diastolic Dysfunction During Ischemia-Reperfusion; J.S. Juggi, et al. 24. Calcium Channel Blockade Ameliorates Cardiac Dysfunction and Failure in Ischemic Cardiomyopathy; J.M. Capasso. 25. Alterations in Autonomic Nervous System and Heart Mitochondrial Function in Rats Treated with Cyclophosphamide; S. Sugiyama, et al. III: Treatment of Heart Failure. 26. Combined Aerobic and Strength Training in CHF Patients: Pilot Project on Safety and Feasibility; R. Gutierrez, et al. 27. Factors Relating to 6 Minute Walk Performance in Heart Failure Patients; M.C. Hendrican, et al. 28. Dynamic Cardiomyoplasty &endash; The Management of Heart Failure Using Autologous Skeletal Muscle; J.N.K. Odim. 29.
